Gentian Diagnostics ASA (OSL: GENT)
Norway
· Delayed Price · Currency is NOK 40.20
+1.20 (3.08%)
Dec 23, 2024, 4:17 PM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 619.98 million as of December 27, 2024. Its market cap has increased by 3.08% in one year.
Market Cap
619.98M
Enterprise Value
532.80M
Revenue
154.12M
Ranking
n/a
PE Ratio
279.26
Stock Price
40.20
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 619.98M, an increase of 114.07%. That is a compound annual growth rate of 9.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nordhealth AS | 3.15B |
| Medistim ASA | 2.75B |
| Photocure ASA | 1.73B |
| Carasent ASA | 1.53B |
| Nykode Therapeutics AS | 986.17M |
| ArcticZymes Technologies ASA | 684.36M |
| Hofseth BioCare ASA | 657.73M |
| Thor Medical ASA | 624.73M |